AstraZeneca may have provided an incomplete view of efficacy data on its Covid-19 vaccine from a large scale trial in the US, a US health agency has said.
from News24 World https://ift.tt/3r7J9fe
via IFTTT
from News24 World https://ift.tt/3r7J9fe
via IFTTT
Post a Comment